Keyphrases
Fat Grafting
89%
Breast Augmentation
86%
Breast Reconstruction
77%
Breast
62%
Breast Implants
56%
Meta-analysis
51%
Atypical Fibroxanthoma
48%
Pleomorphic Dermal Sarcoma
48%
Fat Graft
48%
Gentamicin
39%
Graft Volume
37%
Capsular Contracture
35%
Breast Implant Capsule
34%
Antibiotics
34%
Vancomycin
33%
Porcine Model
32%
Anatomical Implant
32%
Cefazolin
32%
Retrospective Cohort Study
32%
Systematic Meta-analysis
32%
Stromal Vascular Fraction
29%
Volume Retention
28%
Nipple-areola Complex
26%
Implant-based Breast Reconstruction
24%
Risk Factors
23%
Local Recurrence
22%
Stromal Cells
22%
Adipokinetic Hormone
22%
Graft Retention
22%
Implant Rotation
22%
Validation Studies
21%
Breast Volume
21%
Necrosis
18%
Fat Graft Retention
18%
Randomized Controlled Trial
18%
Augmentation Mastopexy
18%
Irrigation
18%
Retrospective Review
18%
Prophylactic Treatment
18%
Mastopexy
18%
Hematoma
18%
Randomized Placebo-controlled Trial
17%
Breast Volumetry
16%
Soft Tissue
16%
Adipose-derived Stromal Cells
16%
National Cohort Study
16%
Treatment Outcome
16%
Population-based
16%
Superomedial Pedicle
16%
Dose-response Study
16%
Medicine and Dentistry
Breast Enlargement
100%
Implant
95%
Breast Implant
80%
Grafting
69%
Breast Reconstruction
62%
Meta-Analysis
51%
Systematic Review
50%
Atypical Fibroxanthoma
48%
Sarcoma
48%
Recurrent Disease
42%
Magnetic Resonance Imaging
39%
Adipose Tissue
38%
Stromal Cell
38%
Capsular Contracture
35%
Retrospective Study
32%
Antibiotics
32%
Retrospective Cohort Study
32%
Metastatic Carcinoma
29%
Gentamicin
26%
Vancomycin
24%
Areola
23%
Prevalence
21%
Placebo
21%
Infection
21%
Necrosis
20%
Mastopexy
19%
Diagnosis
18%
Hematoma
18%
Randomized Controlled Trial
16%
Surgical Infection
16%
Histology
16%
Cefazolin
16%
Adipose Derived Stem Cell
16%
Prophylaxis
16%
Scoring System
16%
Volumetry
16%
Dose Response
16%
Angiosarcoma
16%
Plastic Surgery
16%
Prognostic Factor
16%
Breast Reconstructive Surgery
16%
Breast Reduction
16%
Overall Survival
16%
Pedicle
16%
Biopsy
15%
Surgeon
11%
Medical Record
9%
Epithelization
8%
Promethazine
6%
Evidence-Based Medicine
6%